Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RE1-silencing transcription factor (REST), also known as the neuron-restrictive silencer factor (NRSF), is a master transcriptional repressor that plays a pivotal role in neurogenesis and the maintenance of neuronal identity. It functions by binding to a specific 21-base pair DNA sequence known as the repressor element 1 (RE1) or neuron-restrictive silencer element (NRSE), where it recruits a variety of co-repressor complexes, including CoREST and mSin3, to induce epigenetic modifications such as histone deacetylation and methylation (NIH, 2016; Wikipedia, 2024). While REST is highly expressed in non-neuronal tissues and neural stem cells to silence neuronal genes, its downregulation is essential for the differentiation of neurons (MDPI, 2023). Dysregulation of the REST/NRSF complex is implicated in a wide range of pathologies, including neurodegenerative diseases like Huntington's and Alzheimer's, where aberrant nuclear localization or loss of function contributes to neuronal death (AlzDiscovery, 2021). In oncology, REST acts as a context-dependent oncogene or tumor suppressor; for instance, it is overexpressed in medulloblastoma and glioma but often lost in neuroendocrine tumors like small cell lung cancer (NIH, 2019). Therapeutic strategies targeting the REST/NRSF complex include small molecules that induce its degradation, mimetics that block its interaction with co-repressors, and inhibitors of its associated enzymatic components like HDACs and LSD1 (Protein Science, 2017).
Inhibition of REST-DNA binding, induction of REST degradation, or inhibition of associated co-repressors (HDACs, LSD1) to restore or modulate target gene expression.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RE1-silencing transcription factor (REST) (REST).